Shifting from Ammonium to Phosphonium Salts: A Promising Strategy to Develop Next-Generation Weapons against Biofilms

Silvana Alfei
DOI: https://doi.org/10.3390/pharmaceutics16010080
IF: 6.525
2024-01-07
Pharmaceutics
Abstract:Since they are difficult and sometimes impossible to treat, infections sustained by multidrug-resistant (MDR) pathogens, emerging especially in nosocomial environments, are an increasing global public health concern, translating into high mortality and healthcare costs. In addition to having acquired intrinsic abilities to resist available antibiotic treatments, MDR bacteria can transmit genetic material encoding for resistance to non-mutated bacteria, thus strongly decreasing the number of available effective antibiotics. Moreover, several pathogens develop resistance by forming biofilms (BFs), a safe and antibiotic-resistant home for microorganisms. BFs are made of well-organized bacterial communities, encased and protected in a self-produced extracellular polymeric matrix, which impedes antibiotics' ability to reach bacteria, thus causing them to lose efficacy. By adhering to living or abiotic surfaces in healthcare settings, especially in intensive care units where immunocompromised older patients with several comorbidities are hospitalized BFs cause the onset of difficult-to-eradicate infections. In this context, recent studies have demonstrated that quaternary ammonium compounds (QACs), acting as membrane disruptors and initially with a low tendency to develop resistance, have demonstrated anti-BF potentialities. However, a paucity of innovation in this space has driven the emergence of QAC resistance. More recently, quaternary phosphonium salts (QPSs), including tri-phenyl alkyl phosphonium derivatives, achievable by easy one-step reactions and well known as intermediates of the Wittig reaction, have shown promising anti-BF effects in vitro. Here, after an overview of pathogen resistance, BFs, and QACs, we have reviewed the QPSs developed and assayed to this end, so far. Finally, the synthetic strategies used to prepare QPSs have also been provided and discussed to spur the synthesis of novel compounds of this class. We think that the extension of the knowledge about these materials by this review could be a successful approach to finding effective weapons for treating chronic infections and device-associated diseases sustained by BF-producing MDR bacteria.
pharmacology & pharmacy
What problem does this paper attempt to address?
### What Problem Does This Paper Attempt to Solve? This paper primarily explores how to develop a new generation of drugs against biofilms (Biofilms, BFs). Specifically, the paper focuses on the following aspects: 1. **The Issue of Multidrug-Resistant Pathogens**: - Multidrug-Resistant (MDR) pathogens are particularly common in hospital environments, leading to difficult-to-treat infections, increased mortality rates, and higher medical costs. - These pathogens not only exhibit resistance to existing antibiotics but can also transfer genetic material to non-mutant strains, making them resistant as well. 2. **Biofilm Formation and Resistance**: - Biofilms are self-protective structures formed by bacteria, with an outer layer of extracellular polymeric substances (EPSs) that prevent antibiotics from reaching bacterial cells, thereby making them highly resistant to drugs. - Infections caused by biofilms are very difficult to treat clinically, especially in elderly patients with compromised immune systems in intensive care units. 3. **Limitations of Quaternary Ammonium Compounds (QACs)**: - Quaternary ammonium compounds initially showed potential against biofilms as membrane disruptors, but prolonged use has led to bacterial resistance. 4. **Quaternary Phosphonium Salts (QPSs) as a New Strategy**: - Quaternary phosphonium salts, particularly triphenylalkyl derivatives, are prepared through a simple and low-cost one-step reaction and have shown good bactericidal and anti-biofilm effects in vitro. - The paper reviews the quaternary phosphonium salt compounds developed and tested in recent years and discusses their synthesis strategies to promote the development of new compounds of this type. In summary, this paper aims to address the current challenges in treating infections caused by multidrug-resistant pathogens and biofilms by researching quaternary phosphonium salts as a new generation of anti-biofilm drugs.